drugset / Trial / NCT00170911
Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.
RandomizedParallel-groupDouble-blindTreatment
Summary
AAE581 is a specific inhibitor of the cysteine protease cathepsin K. This trial is designed to provide detailed information about the effects( efficacy and safety) of AAE581 on Bone Mineral Density.
Timeline
- Start
- 2005-03
- Primary completion
- 2005-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | balicatib | Small molecule | — | — |